CD25+CD4+ regulatory T cells in patients with Kawasaki disease

J Pediatr. 2004 Sep;145(3):385-90. doi: 10.1016/j.jpeds.2004.05.048.

Abstract

Objective: To investigate whether the CD25 + CD4 + regulatory T-cell population, which plays important roles not only in maintaining immunologic self-tolerance but also in controlling the magnitude and character of antimicrobial immune responses, is related to the pathophysiology of Kawasaki disease (KD).

Study design: The patient group consisted of 54 patients (median age, 30 months; 27 female and 27 male patients) fulfilling the criteria for KD. Age-matched control subjects included 17 patients with active infections and 24 healthy children. We analyzed CD25 + CD4 + cells and the mRNA expression of Foxp3, cytotoxic T lymphocyte-associated antigen 4 (CTLA4), glucocorticoid-induced tumor necrosis factor receptor (GITR), and transforming growth factor beta in peripheral blood mononuclear cells and purified CD4 + T cells.

Results: The proportions of CD25 + CD4 + cells in patients with acute-phase KD (median, 2.35% of total lymphocytes) were significantly lower than those in healthy control subjects (median, 3.14%) and control subjects with disease (median, 3.15%). The proportions returned to the normal level after intravenous gammaglobulin treatment (median, 3.86%). The mRNA expression of Foxp3, CTLA4, and GITR showed similar tendencies.

Conclusions: The decrease of CD25 + CD4 + regulatory T cells in the acute phase might have a role in the development of KD.

MeSH terms

  • CD4 Antigens / blood
  • CD4 Antigens / genetics
  • CD4 Antigens / immunology*
  • Case-Control Studies
  • Child, Preschool
  • Female
  • Flow Cytometry
  • Humans
  • Male
  • Mucocutaneous Lymph Node Syndrome / genetics
  • Mucocutaneous Lymph Node Syndrome / immunology*
  • Mucocutaneous Lymph Node Syndrome / physiopathology
  • Receptors, Interleukin-2 / blood
  • Receptors, Interleukin-2 / genetics
  • Receptors, Interleukin-2 / immunology*
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • CD4 Antigens
  • Receptors, Interleukin-2